Oral complications in a paediatric graft versus host disease (GVHD) clinic: A retrospective study

被引:1
|
作者
Emperumal, Chitra Priya [1 ,5 ]
Weller, Brett [2 ]
Okane, Sara [3 ]
Joseph, Renita [3 ]
Kharbanda, Sandhya [3 ]
Ling, Zhan [1 ]
Villa, Alessandro [1 ,4 ]
机构
[1] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Dent, San Francisco, CA USA
[3] Univ Calif San Francisco, Paediat Bone Marrow Transplant Program, San Francisco, CA USA
[4] Florida Int Univ, Miami Canc Inst, Herbert Wertheim Coll Med, Dept Translat Med,Baptist Hlth South Florida, Miami, FL USA
[5] Univ Calif San Francisco, Dept Orofacial Sci, 513 Parnassus Ave, s722, San Francisco, CA 94143 USA
关键词
allogeneic bone marrow transplants; oral cGHVD; oral manifestations; paediatric population; CONSENSUS DEVELOPMENT PROJECT; HEMATOPOIETIC-CELL TRANSPLANTATION; MANAGEMENT; CRITERIA; TRIALS; HEALTH; XEROSTOMIA; DIAGNOSIS; SURVIVORS; CHILDREN;
D O I
10.1111/odi.14535
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective: The aim of this study was to investigate the oral health status among allogeneic transplant recipients who were seen in a multidisciplinary graft-versus-host disease paediatric clinic at the University of California, San Francisco (UCSF).Methods: This was a retrospective cohort study of patients who underwent allogeneic transplants and were seen in the graft-versus-host disease paediatric clinic between January 2010 and September 2021. Demographic, medical and oral health data were recorded and analysed using descriptive statistics.Results: A total of 25 patients were seen in the paediatric graft-versus-host disease clinic (68% males) with a median age of 12 years at the time of transplant were included. Among them, 12 patients (48%) were diagnosed with oral chronic GVHD, 11 (44%) with dry mouth, four (16%) with oral pseudomembranous candidiasis, one (4%) with recrudescent Herpes Simplex Virus (HSV) infection and one (4%) with mammalian target of rapamycin-inhibitor stomatitis and were managed by the oral medicine team, accordingly with medications, such as topical steroids (44%) and anti-fungal (20%).Conclusions: HSCT recipients may present with a variety of oral complications. Patients may benefit by a multi-disciplinary approach including a dental specialist as part of the cancer care team.
引用
收藏
页码:1084 / 1090
页数:7
相关论文
共 50 条
  • [1] Establishing a Graft-Versus-Host Disease (GVHD)-Focused Multidisciplinary Telehealth Clinic
    Harris, Andrew C.
    Markova, Alina
    Devlin, Sean
    Singh, Amandeep
    Susman, Pamela
    Brown, Soni
    Grasso, Christine
    Custodio, Christian
    Estilo, Cherry
    Ibanez, Katarzyna
    Myers, Michelle
    Syrkin, Grigory
    Yom, Saehee
    Perales, Miguel-Angel
    Ponce, Doris M.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (12): : 1215e1 - 1215e11
  • [2] Treatment of oral chronic graft-versus-host disease: a retrospective cohort study
    Ramos, Gabriela de Assis
    Boehmer Leite, Taisa Domingues
    Lobo, Camila Brandao
    da Silva Santos, Paulo Sergio
    Rodrigues Moreira, Maria Claudia
    Antunes, Heliton Spindola
    EINSTEIN-SAO PAULO, 2021, 19 : eAO6177
  • [3] Oral lesions in paediatric patients with graft-versus-host disease
    Condo, R.
    Maturo, P.
    Perugia, C.
    Docimo, R.
    EUROPEAN JOURNAL OF PAEDIATRIC DENTISTRY, 2011, 12 (01) : 50 - 54
  • [4] Chronic Graft-Versus-Host Disease (GVHD) in Children
    Baird, Kristin
    Cooke, Kenneth
    Schultz, Kirk R.
    PEDIATRIC CLINICS OF NORTH AMERICA, 2010, 57 (01) : 297 - +
  • [5] Ocular graft versus host disease. Corneal complications
    Westekemper, H.
    Scholz, S. L.
    Thomasen, H.
    Halfwassen, C.
    Steuhl, K-P
    OPHTHALMOLOGE, 2017, 114 (08): : 697 - 702
  • [6] Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study
    Arora, M.
    Pidala, J.
    Cutler, C. S.
    Chai, X.
    Kurland, B.
    Jacobsohn, D. A.
    Pavletic, S. Z.
    Palmer, J.
    Vogelsang, G.
    Jagasia, M.
    Schultz, K.
    Lee, S. J.
    LEUKEMIA, 2013, 27 (05) : 1196 - 1201
  • [7] Immunohistopathology of oral mucosal chronic graft-versus-host disease severity and duration
    Tollemar, Victor
    Strom, Jennifer
    Tudzarovski, Nikolce
    Habel, Henrike
    Legert, Karin Garming
    Heymann, Robert
    Warfvinge, Gunnar
    Le Blanc, Katarina
    Sugars, Rachael Victoria
    ORAL DISEASES, 2023, 29 (08) : 3346 - 3359
  • [8] Murine models of graft versus host disease (GVHD): Focus on ocular GVHD
    Steven, Philipp
    Perez, Victor L.
    Sharma, Ajay
    OCULAR SURFACE, 2023, 30 : 179 - 186
  • [9] The Effectiveness of Ruxolitinib for Acute/Chronic Graft-versus-Host Disease in Children: A Retrospective Study
    Yang, Wenli
    Zhu, Guanghua
    Qin, Maoquan
    Li, Zhigang
    Wang, Bin
    Yang, Jun
    Wang, Tianyou
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 743 - 752
  • [10] Oral Disease Profiles in Chronic Graft versus Host Disease
    Bassim, C. W.
    Fassil, H.
    Mays, J. W.
    Edwards, D.
    Baird, K.
    Steinberg, S. M.
    Cowen, E. W.
    Naik, H.
    Datiles, M.
    Stratton, P.
    Gress, R. E.
    Pavletic, S. Z.
    JOURNAL OF DENTAL RESEARCH, 2015, 94 (04) : 547 - 554